Cargando…
Prophylactic use of pegfilgrastim enables the management of severe neutropenia without dose delays in patients with metastatic colorectal cancer treated with TAS-102 plus bevacizumab
Combined treatment with bevacizumab and trifluridine/tipiracil (TAS-102) leads to an increased chance of survival in patients with refractory metastatic colorectal cancer (mCRC); however, this treatment is associated with an increased frequency of severe neutropenia (number of neutrophils <1,000)...
Autores principales: | Tamaki, Sawako, Ishikawa, Hideki, Suzuki, Koichi, Kimura, Yasuaki, Maemoto, Ryo, Abe, Iku, Endo, Yuhei, Kakizawa, Nao, Watanabe, Fumiaki, Futsuhara, Kazushige, Saito, Masaaki, Tsujinaka, Shingo, Miyakura, Yasuyuki, Rikiyama, Toshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022083/ https://www.ncbi.nlm.nih.gov/pubmed/35463210 http://dx.doi.org/10.3892/mco.2022.2536 |
Ejemplares similares
-
Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report
por: Fukui, Taro, et al.
Publicado: (2019) -
Effect of Antithrombotic Therapy on Secondary Bleeding After Proctological Surgery
por: Maemoto, Ryo, et al.
Publicado: (2021) -
Mid-term Efficacy of Local Repair Using Modified Altemeier Technique for Stomal Prolapse: A Case Series
por: Tsujinaka, Shingo, et al.
Publicado: (2022) -
Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer
por: Watanabe, Fumiaki, et al.
Publicado: (2019) -
Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients
por: Watanabe, Fumiaki, et al.
Publicado: (2021)